Abstract

Most estimates of disease burden due to infectious diseases focus on the impact of acute infections and do not fully capture the effects of (long-term) sequelae. To provide evidence-based and comparable estimates, the European Centre for Disease Prevention and Control (ECDC), the Dutch National Institute of Public Health and the Environment (RIVM), and other institutions collaborated in the Burden of Communicable Diseases in Europe (BCoDE) project.

DAL Ys were estimated through an incidence- and pathogen-based approach. The main data source for incidence of acute disease was the (age- and sex-specific) number of cases notified to The European Surveillance System (TESSy) between 2009 and 2013. Alternative methods for estimating incidence were used when necessary. The availability and quality of TES Sy data were assessed across reporting years and countries, and notified cases were averaged to one year and corrected for under-estimation. Disability weights were derived from a European study following protocols established for the Global Burden of Disease project. Calculation of DAL Ys was performed with the BCoDE software toolkit without applying time discounting and age-weighting.

At this lecture, Mirjam Kretzschmar, University Medical Center Utrecht, The Netherlands, and Center for Infectious Disease Control, RIVM , The Netherlands, will present some results on burden of infectious diseases in Europe and in the Netherlands.

Chaired by Dr Anne Presanis, MRC Biostatistics Unit.